Floatz logo

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-

Lymphoid Malignancies

National Cancer Institute (NCI)Small moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Lymphoid Malignancies cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Case Comprehensive Cancer Center
Phase 2BB
Abt-263
AbbVie
Phase 1/2B
Pralatrexate
Jennifer Amengual
Phase 1/2CCC
Venetoclax
National Cancer Institute (NCI)
Phase 1/2CCC
Romidepsin
Columbia University
Phase 1/2CCC

View all 21 →

Same molecule, other indications

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:

Alzheimer DementiaDormant
BB
Indicative ·
66 / 100
View asset →
Essential TremorDormant
B
Indicative ·
63 / 100
View asset →
Breast CancerDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →